Commerce Bank increased its position in shares of CVS Health Corporation (NYSE:CVS) by 2.5% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 417,935 shares of the pharmacy operator’s stock after buying an additional 10,030 shares during the period. Commerce Bank’s holdings in CVS Health Corporation were worth $40,014,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently modified their holdings of the stock. MU Investments Co. Ltd. boosted its stake in shares of CVS Health Corporation by 62.0% in the second quarter. MU Investments Co. Ltd. now owns 1,150 shares of the pharmacy operator’s stock worth $109,000 after buying an additional 440 shares in the last quarter. Springbok Capital Management LLC boosted its stake in shares of CVS Health Corporation by 190.5% in the first quarter. Springbok Capital Management LLC now owns 1,130 shares of the pharmacy operator’s stock worth $117,000 after buying an additional 741 shares in the last quarter. Global X Management Co. LLC boosted its stake in shares of CVS Health Corporation by 93.5% in the second quarter. Global X Management Co. LLC now owns 1,362 shares of the pharmacy operator’s stock worth $130,000 after buying an additional 658 shares in the last quarter. Alexandria Capital LLC boosted its stake in shares of CVS Health Corporation by 3.4% in the second quarter. Alexandria Capital LLC now owns 1,405 shares of the pharmacy operator’s stock worth $135,000 after buying an additional 46 shares in the last quarter. Finally, Arcadia Investment Management Corp MI boosted its stake in shares of CVS Health Corporation by 87.7% in the second quarter. Arcadia Investment Management Corp MI now owns 1,605 shares of the pharmacy operator’s stock worth $154,000 after buying an additional 750 shares in the last quarter. Institutional investors own 80.96% of the company’s stock.

CVS Health Corporation (NYSE:CVS) traded up 0.22% on Friday, reaching $90.77. 1,962,367 shares of the company traded hands. The stock has a market capitalization of $96.78 billion, a price-to-earnings ratio of 20.88 and a beta of 0.84. The stock has a 50 day moving average of $94.22 and a 200-day moving average of $97.87. CVS Health Corporation has a 1-year low of $86.50 and a 1-year high of $106.67.

CVS Health Corporation (NYSE:CVS) last issued its quarterly earnings results on Tuesday, August 2nd. The pharmacy operator reported $1.32 EPS for the quarter, topping the consensus estimate of $1.30 by $0.02. The company earned $43.70 billion during the quarter, compared to analyst estimates of $44.28 billion. CVS Health Corporation had a net margin of 2.88% and a return on equity of 15.86%. The firm’s revenue was up 17.6% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $1.19 EPS. On average, equities analysts anticipate that CVS Health Corporation will post $5.86 EPS for the current year.

The firm also recently announced a quarterly dividend, which will be paid on Thursday, November 3rd. Stockholders of record on Monday, October 24th will be issued a dividend of $0.425 per share. This represents a $1.70 dividend on an annualized basis and a dividend yield of 1.88%. CVS Health Corporation’s payout ratio is 39.08%.

A number of analysts have commented on the stock. Credit Suisse Group AG reaffirmed a “buy” rating and set a $115.00 target price on shares of CVS Health Corporation in a report on Tuesday. Morgan Stanley reaffirmed a “hold” rating and set a $104.00 target price on shares of CVS Health Corporation in a report on Monday, September 12th. Citigroup Inc. reduced their price objective on shares of CVS Health Corporation from $115.00 to $108.00 and set a “neutral” rating for the company in a research note on Monday, August 8th. Argus reissued a “buy” rating and issued a $120.00 price objective on shares of CVS Health Corporation in a research note on Thursday, August 4th. Finally, Mizuho increased their price objective on shares of CVS Health Corporation from $108.00 to $111.00 and gave the stock a “buy” rating in a research note on Thursday, August 4th. Six research analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and one has assigned a strong buy rating to the stock. CVS Health Corporation currently has a consensus rating of “Buy” and an average price target of $113.02.

About CVS Health Corporation

CVS Health Corporation, together with its subsidiaries, is a pharmacy company. The Company operates through three business segments: Pharmacy Services, Retail Pharmacy and Corporate. The Pharmacy Services segment provides a range of pharmacy benefit management (PBM) services and operates under the CVS/caremark Pharmacy Services, Novologix and Navarro Health Services names.

5 Day Chart for NYSE:CVS

Receive News & Ratings for CVS Health Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health Corporation and related companies with MarketBeat.com's FREE daily email newsletter.